Bellevue Group AG NBIX Holdings History
Bellevue Group AG's Neurocrine Biosciences Inc Holding Summary
As of 2025-03-31, Bellevue Group AG held 1.82 Mil shares of Neurocrine Biosciences Inc(NBIX), totaling $201.29 Mil. This investment constitutes 4.51% of their stock portfolio, and Bellevue Group AG now holds 1.84% of the outstanding Neurocrine Biosciences Inc(NBIX) stock.
The initial trade took place in 2018Q2. And since then Bellevue Group AG has made 6 purchases of NBIX, at an average price of $83.80, for a total of 3.96 Mil shares. In addition, there have been 21 sales at an average price of $109.59 for 2.14 Mil shares. Based on historical transaction data and NBIX's current price of $132.02, Bellevue Group AG's estimated gain on his NBIX holdings is $143.01 Mil, reflecting a 43.06% gain to date.
Bellevue Group AG NBIX ($132.02) Holding Chart
Bellevue Group AG NBIX ($132.02) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
